Design of the FRAIL-AF trail: safety of switching from VKA to DOAC in frail elderly with atrial fibrillation

ISTH Academy, Linda Joosten, 264339

An intracardiac thrombus Associated With Antithrombin Deficiency with a Novel Mutation c.1063T>G in SERPINC1

ISTH Academy, Larfi Yacine, 264359

Cardiovascular diseases and use of antithrombotic agents in patients with end-stage renal disease on hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in hemoDIalysis patients (VIVALDI)

ISTH Academy, Oliver Königsbrügge, 264360

Regulation of Smooth Muscle Cell Phenotype and Neointima Formation by Endothelial Cell- Secreted MicroRNA-21

ISTH Academy, Mao Luo, 264361

Assessment of single-factor deficiency sensitivity of three APTT reagents

ISTH Academy, Claire Martin, 264376

Toll-like receptor 9 activation robustly enhances germinal center and inhibitor formation in response to factor VIII

ISTH Academy, Radoslaw Kaczmarek, 264377

The Calibrated Automated Thrombinography for hemophilia treatment monitoring

ISTH Academy, Natalya Silina, 264378

Comparison of factor VIII half-life as determined using two web-accessible population-based pharmacokinetic applications

ISTH Academy, Jerome Teitel, 264379

Increased platelet contribution to clot strength in cirrhotic patients with non-malignant recent portal vein thrombosis

ISTH Academy, Ecaterina Scarlatescu, 264393

ERK activation was associated with transfusion-related acute lung injury in C-reactive protein-enhanced antibody-mediated murine model of transfusion-related acute lung injury

ISTH Academy, Chih-Chun Chang, 264394

Haemostatic Profiles and Hepatic Dysfunction in Fontan Patients

ISTH Academy, Vera Ignjatovic, 264395

Effects of acute liver failure of Yellow Fever infection on haemostasis assessed by thromboelastometry

ISTH Academy, Letícia Lemos Jardim, 264396

Data interpretation of the ETP-based APC resistance assay and the concept of nAPCsr10, an improved nAPCsr

ISTH Academy, Laure Morimont, 264410

Detection of direct intramembrane interaction between the endothelial protein C receptor and thrombomodulin

ISTH Academy, Ingmar Schoen, 264411

Endothelial Protein C Receptor (EPCR) Levels and EPCR Gene A3 Haplotype in Patients with Sickle Cell Anemia

ISTH Academy, ANIL Tombak, 264412

Understanding the mechanisms of Acquired Protein S Deficiency in Sickle Cell Disease

ISTH Academy, Morayma Reyes-Gil, 264413

Effect of catechins on blood coagulation and on various proteins related to the regulation of blood coagulation which are produced in HepG2 Cells

ISTH Academy, Tatsuya Hayashi, 264428

Defective Zn2+ homeostasis in mouse and human platelets with α- and δ-storage pool disorders

ISTH Academy, Elmina Mammadova-Bach, 264429

Heme induces expression and activation of hematopoietic tissue factor via TLR4 and PDIA3-dependent signaling pathways

ISTH Academy, Bidossessi Wilfried Hounkpe, 264431

Crosslinking of Poly(vinyl) Alcohol Hydrogels Determines Material Thrombogenicity

ISTH Academy, Novella Bates, 264432

Potential role of high-sensitive troponin T in identification of patients with pulmonary embolism (PE) who may be treated safely at home?

ISTH Academy, Stephan Vincent Hendriks, 264448

Coagulation activation in Sickle cell Disease and the effect of Hydroxyurea

ISTH Academy, Munira Borhany, 264449

Immuno-Magnetic Separation allows Antigen-specific extraction of Microvesicle subsets for measurement of TF-dependent procoagulant activity. A proof of concept using pleural fluids containing tumor-derived vesicles

ISTH Academy, Romaric Lacroix, 264450

Global coagulation assays in patients with multiple myeloma and monoclonal gammopathy of unknown significance

ISTH Academy, Rowena Brook, 264451

No change in coagulation factor levels after knee arthroscopy

ISTH Academy, Carolina Eveline Touw, 264466

Integrated GWAS and Gene Expression Data Identifies ORM1 as Potential Regulator of Plasma Cell-free DNA Levels in Families of the GAIT2 Project

ISTH Academy, José Manuel Soria, 264467

Effects of veno-venous extracorporeal membrane oxygenation on coagulation factors- a prospective observational study

ISTH Academy, Deepa Jayakody Arachchillage, 264468

TEG-BASED EVALUATION OF GENDER-ASSOCIATED HYPERCOAGULABILITY

ISTH Academy, Kristen Carter, 264483

Thrombin generation and endothelial dysfunction in patients with systemic sclerosis

ISTH Academy, Jerzy Dropinski, 264484

Assessment of Factor IX Padua activity with a one-stage clotting method and with FXIa- and tissue factor/FVIIa-based chromogenic methods

ISTH Academy, Steffen Rosen, 264485

Comparison of one stage APTT FVIII assay and chromogenic factor (F) VIII assays in patients with severe Haemophilia A, receiving FVIII treatment products

ISTH Academy, Anne Riddell, 264500

Quantitative and qualitative differences exist between APTT reagents in clot waveform analysis in haemophilic plasma spiked with normal plasma and rFVIII products

ISTH Academy, Geoff Kershaw, 264502

Assays performed on samples containing emicizumab - data from a multicentre study of UK NEQAS Blood Coagulation (BC) laboratories

ISTH Academy, Ian Jennings, 264503

Phenotypic Variability in Antiplatelet and Anticoagulant Therapy in African Americans: An ACCOuNT Consortium Study

ISTH Academy, Minoli Perera, 264517

COMPARISON BETWEEN PLATELETWORKS METHOD AND AGGREGATION WITH PLATELET-RICH PLASMA FOR THE EVALUATION OF PLATELET FUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME

ISTH Academy, Mirta Del Valle Arias, 264518

The Total Thrombus Formation (T-TAS) Platelet Assay, a novel point-of-care test that uses arterial shear stress evaluating antiplatelet therapy

ISTH Academy, kailiang zheng, 264519

A multimodal approach using tranexamic acid plus fibrinogen compensates low levels of thrombin generation following PCC therapy in a polytrauma model

ISTH Academy, Oliver Grottke, 264537

Streptokinase and staphylokinase: mechanisms underlying the differences in their thrombolytic and fibrinogenolytic effects

ISTH Academy, Roza Aisina, 264539

Interaction of cationic and anionic of polyamidoamine dendrimers with plasminogen: influence on the structure and activation of zymogen by streptokinase

ISTH Academy, Liliya Mukhametova, 264540

Peptides derived from basement membrane hydrolysis by snake venom metalloproteinases contribute to the vascular effects of viper venoms

ISTH Academy, Ana M. Moura-da-Silva, 264558

Differences in the hemostatic disturbances in snakebite patients and eventual role of individual snake venom composition

ISTH Academy, Ana M. Moura-da-Silva, 264559

Acquired FXIII inhibitor: patient characteristics and treatment outcome, a case series

ISTH Academy, Sheng-Chieh Chou, 264560

Combination of cyclophosphamide and corticosteroids therapy facilitate remission in acquired hemophilia A patients with high titers of inhibitors: A single center experience in China

ISTH Academy, Naifang Ye, 264574

Three successful cases of AHA patients presenting severe cardiovascular diseases treated with susoctocog-alfa (rpFVIII): a single centre experience

ISTH Academy, Ezio Zanon, 264576

Acquired Hemophilia A with an exorbitant inhibitor and venous thrombosis: successfull treatment with recombinant porcine FVIII plus recombinant FVIIa and immediate anti-CD20 therapy

ISTH Academy, Wolfgang Korte, 264577

Long-term safety of N8-GP (turoctocog alfa pegol) prophylaxis in patients with severe haemophilia A

ISTH Academy, Nicola J Curry, 264591

Non-adherence to treatment may have a direct relationship to lower bleeding rate in hemophilia A (APT Project)

ISTH Academy, Ricardo Camelo, 264592

Treatment Patterns and Outcomes in Persons with Hemophilia A (PwHA): Analysis from the CHOICE Survey in the United States

ISTH Academy, Anisha M. Patel, 264594

Haemostatic therapy for insertion of central venous access devices in severe haemophilia A and B - Melbourne paediatric protocol

ISTH Academy, Sally Campbell, 264608

Predictors of bleeding in severe Haemophilia A

ISTH Academy, Samuel Sarmiento Doncel, 264609

Incidence and Prevalence of Diagnosed and Undiagnosed Hemophilia A and Hemophilia B in Select Countries

ISTH Academy, Emily S. Brouwer, 264610

Comparing Qualitative and Quantitative Data on BAY 94-9027, a New Extended Half-Life Recombinant Factor VIII for the Treatment of Hemophilia A: A Mixed- Method Research Approach.

ISTH Academy, Emilio Musi, 264624

Review of a Port-A-Cath Training Programme for Caregivers in a Paediatric Haemophilia Treatment Centre

ISTH Academy, Chiew Ying Lim, 264625

Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa) in Spain

ISTH Academy, Santiago Bonanad, 264626

Prediction of anti-FVIII inhibitor persistence by anti-FVIII IgG subclasses in patients with severe hemophilia a in the SIPPET cohort study

ISTH Academy, Roberta Palla, 264641

Bone Health In Hemophilic Arthropathy- A Systematic Study from Eastern India

ISTH Academy, PRAKAS Mandal, 264642

Long-term efficacy and safety of recombinant factor IX fusion protein (rIX-FP) in previously treated patients with hemophilia B: Results from a phase 3b extension study

ISTH Academy, Maria Elisa Mancuso, 264643

Comorbidity and transfusion transmitted infections in patients with severe haemophilia: Report from Taiwan Society of Thrombosis and Hemostasis registry

ISTH Academy, Jiaan-Der Wang, 264658

Structure, mechanical and lytic stability of fibrin and plasma coagulum generated by staphylocoagulase from Staphylococcus aureus

ISTH Academy, Craig Thelwell, 264659

Systemic Antifibrinolytic Agents for Hemoptysis Management in Adults with Cystic Fibrosis

ISTH Academy, Jean Connors, 264662

Efficacy of Three Factor Prothrombin Complex in Achieving Haemostasis in Patients with Major Bleeding on Anti-Coagulation - Retrospective Single Centre Study

ISTH Academy, Usha Chandra Sekaran, 264677

GPVI shedding contributes to platelet dysfunction in trauma-induced coagulopathy

ISTH Academy, Samantha Montague, 264678

Efficacy and safety of a 4-factor prothrombin complex concentrate for management of direct Xa inhibitor-induced major bleeding

ISTH Academy, Paul P Dobesh, 264679

Endothelial dysfunction, oxidative stress and activation of Rho A/Rho kinase pathway in major depressive disorder

ISTH Academy, Claudia Saez, 264694

Molecules derived from procoagulant lipocalin (Lopap) as potential hits on blood coagulation, cytoprotection and tissue remodeling

ISTH Academy, Ana Chudzinski-Tavassi, 264695

Decreased Thrombin Generation Potential is Associated with Increased Thrombin Generation Markers in Sepsis Associated Coagulopathy

ISTH Academy, Fakiha Siddiqui, 264696

Non-coding RNA miR-365a-3p Suppresses Tissue Factor Levels and Decreases Thrombin Generation

ISTH Academy, Jiayin Tian, 264711

Developing a novel stem cell and gene therapy system based on resveratrol-induced HSP70 promoter-regulated VEGFA expression

ISTH Academy, KowitYu Chong, 264712

Prolonged therapeutic effects of adipose-derived stem cells via the photoactivation after ischemic injury

ISTH Academy, Jianbo Wu, 264713

All-trans retinoic acid (ATRA) impairs platelet function and thrombus formation and inhibits protein kinase C βI and δ phosphorylation

ISTH Academy, Jianlin Qiao, 264727

The mammalian target of rapamycin controls platelet integrin activation, aggregation, and ischemic stroke

ISTH Academy, Robert Campbell, 264728

Lenalidomide and dexamethasone enhanced platelet activation and in vitro thrombus formation under arterial flow

ISTH Academy, Fehaid Alanazi, 264729

Potential for ice recrystallisation inhibitors to improve cryopreserved platelet recovery and quality

ISTH Academy, Lauren Waters, 264745

The role of NMDA receptors in platelet specific hemostasis

ISTH Academy, Lili Donner, 264746

Elevated soluble GPVI levels in patients with symptomatic aortic stenosis and left ventricular remodelling

ISTH Academy, Cecile Oury, 264747

Ceruloplasmin reduces the ability of thrombin to cause platelet aggregation

ISTH Academy, Irina Gorudko, 264762

Effect of monomeric myeloperoxidase on platelet function

ISTH Academy, Irina Gorudko, 264763

Platelets are associated with reduced survival in lung adenocarcinoma patients and promote metastatic dissemination in murine models

ISTH Academy, Stephanie R. Hyslop, 264764

EFFICACY AND PK/PD RELATIONSHIP OF RECOMBINANT ADAMTS13 (TAK-755) IN A HUMANIZED MOUSE MODEL OF SICKLE CELL DISEASE

ISTH Academy, Michael Dockal, 264780

Recombinant ADAMTS13 (TAK-755/SHP655) can override the inhibitory effect of free hemoglobin on von Willebrand factor (VWF) multimer cleavage in vitro

ISTH Academy, Werner Hoellriegl, 264781

Dose-dependent effects of recombinant ADAMTS13 (TAK-755/SHP655) on recovery in a humanized mouse model of sickle cell disease

ISTH Academy, Werner Hoellriegl, 264782

Red blood cells transfusion can improve hemostatic dysfunction of Heyde Syndrome

ISTH Academy, Ayaka Kakiwaki, 264797

Acquired thrombotic thrombocytopenic purpura occurring in advanced age: impact of a delayed onset on disease expression

ISTH Academy, Andrea Artoni, 264798

Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura

ISTH Academy, Ilaria Mancini, 264799

Initial thrombus above or below popliteal fossa is more predictive than residual thrombosis for postthrombotic syndrome after episode of deep venous thrombosis - RIETE experience with 1183 patients

ISTH Academy, Marijan Bosevski, 264814

Sex-specific Differences in the Clinical Presentation, Surgical Complications, and Course of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Insights from the European CTEPH Registry

ISTH Academy, Stefano Barco, 264815

Post-thrombotic syndrome, some unexpected results

ISTH Academy, Mohamed Habib Houman, 264816

Trends in referrals to an ambulatory deep vein thrombosis service over ten years at Cambridge University NHS Foundation Trust

ISTH Academy, Will Thomas, 264831

Features of thrombosis of the vena cava on a series of 1045 vein thrombosis

ISTH Academy, Mohamed Habib Houman, 264832

MRDTI Can Distinguish Between Old and New Thrombosis in the Abdominal Aorta: A Case Report

ISTH Academy, Lisette F. van Dam, 264833

CEREBRAL VENOUS THROMBOSIS RISK FACTORS

ISTH Academy, Milan Kostal, 264847

Cerebral venous thrombosis: a study about 1045 cases

ISTH Academy, Mohamed Habib Houman, 264848

Recurrences after Splanchnic Vein Thrombosis: Risk Factors and Efficacy of Vitamin K-Antagonists in a Retrospective Monocenter Cohort of 207 Patients

ISTH Academy, Valerio De Stefano, 264849

Safety and Efficacy of Full Dose Dabigatran in the Treatment of Deep Vein Thrombosis in a Very Young Adolescent

ISTH Academy, Franco Piovella, 264864

Direct Oral Anticoagulant Laboratory Assay Assessment at a Large Academic Medical Center

ISTH Academy, Sharonlin Bhardwaj, 264865

The CTPA Epidemic?

ISTH Academy, Sarah Kelliher, 264866

Thrombin generationin Chinese pregnant women and the effect of insulin useon thrombin generation in GDM patients

ISTH Academy, Xiaowei Qi, 264887

Changes in the thrombocytic link of the hemostasis system in pregnant women with preeclampsia

ISTH Academy, Bakhodir Kurbanov, 264888

Transfusions during pregnancy or postpartum in 3 Italian Tertiary level Obstetrics Departments: A retrospective analysis

ISTH Academy, Elvira Grandone, 264890

Inherited thrombophilia in infertility patients in Macedonia

ISTH Academy, Elena Petkovikj, 264906